Richard Goldstein, MD, PhD, MHCM, is an endocrine surgeon and healthcare executive with expertise spanning complex operative care and large-scale clinical enterprise leadership. He currently serves as a Venture Partner at Dria Ventures and is a Board Director at Senscio Systems, advising and investing in innovations that improve care delivery, quality, and efficiency. Clinically, Dr. Goldstein focuses on advanced endocrine surgery, including thyroid and parathyroid surgery, multidisciplinary perioperative care, and complex surgical decision-making. His research interests include endocrine physiology and molecular mechanisms, AI-enabled approaches to monitoring and care optimization, and health services innovation to advance value-based, high-reliability healthcare. He has held senior leadership roles across major health systems, including Vice President and Chief Medical Officer at Yale New Haven Health System’s Northeast Medical Group and Interim President of the network, as well as Vice Dean of Clinical Affairs and Chief of Surgical Oncology at the University of Louisville and president-level roles within Central Maine Healthcare. His achievements include holding the Kenneth F. vonRoenn, M.D. Family Chair in Surgical Endocrinology and being recognized as a patient safety champion for advancing high-reliability practices and cultures of situational awareness. He earned his MD from Thomas Jefferson University, completed a surgery residency at Vanderbilt University School of Medicine, received a PhD in Molecular Physiology and Biophysics at Vanderbilt, and completed a Master in Health Care Management at Harvard University.
Hospital Leadership
Medical School
1978 – 1982
Residency
1982 – 1990